Latest News about PFE
Recent news which mentions PFE
From Benzinga
 
   Get Your Money Out of These 3 Dividend Stocks by 2025
   
  
  
  July 26, 2024
  From InvestorPlace
 
   What's Going On With Pfizer Stock Thursday?
   
  
  
  July 25, 2024
  From Benzinga
 From InvestorPlace
 From Motley Fool
 
   Beware, Wegovy -- Pfizer Is Working on a Competitor
   
  
  
  July 25, 2024
  From Motley Fool
 
   Why Is Sangamo Therapeutics (SGMO) Stock Up 40% Today?
   
  
  
  July 24, 2024
  From InvestorPlace
 From Benzinga
 Tickers 
   PFE
  
  
  From Motley Fool
 
   Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
   
  
  
  July 24, 2024
  From Benzinga
 
   Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants
   
  
  
  July 23, 2024
  From Benzinga
 
   Pfizer And GSK's ViiV Healthcare's Two-Drug HIV Treatment Matches Gilead's Three-Drug Combo In Major Trial
   
  
  
  July 23, 2024
  From Benzinga
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  July 23, 2024
  From Benzinga
 From Benzinga
 From Motley Fool
 
   Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
   
  
  
  July 21, 2024
  From Motley Fool
 Tickers 
   PFE
  
  
  From Motley Fool
 
   EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
   
  
  
  July 18, 2024
  From Benzinga
 
   COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
   
  
  
  July 18, 2024
  From Benzinga
 
   Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst
   
  
  
  July 18, 2024
  From Benzinga
 From Benzinga
 
   Pfizer/Valneva's Vaccine Study For Tick-Borne Infection Completes Primary Vaccination Series, Plans Approval In 2026
   
  
  
  July 18, 2024
  From Benzinga
 
   Pfizer Stock Nears Golden Cross, Signals Potential Upside With Strong Oncology Portfolio
   
  
  
  July 18, 2024
  From Benzinga
 From Benzinga
 
   7 Hated Stocks Set to Make a Major Comeback This Year
   
  
  
  July 18, 2024
  From InvestorPlace
 
   Alnylam Stock Is a Blockbuster Biopharma In the Making
   
  
  
  July 18, 2024
  From InvestorPlace
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
